Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Breier

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Psychopharmacology|April 10, 2023
Evidence of trospium's ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study resultsAlan Breier, Stephen K Brannan, Steven M Paul, et al.
Early Intervention in Psychiatry|November 29, 2023
Early phase psychosis and criminal conviction in United States adultsKyle D Webster, Tracy D Gunter, Jenifer L Vohs, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 19, 2002
Amphetamine-induced dopamine release and post-synaptic specific binding in patients with mild tardive dyskinesiaCaleb M Adler, Anil K Malhotra, Igor Elman, et al.
The Journal of Clinical Psychiatry|April 11, 2025
Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia: PANSS-Excited Component Results From 3 Randomized, Double-Blind, Placebo-Controlled EMERGENT TrialsPaul P Yeung, Alan Breier, Haiyuan Zhu, et al.
The American Journal of Psychiatry|August 6, 2003
The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumesCelso Arango, Alan Breier, Robert McMahon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 26, 2003
Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trialPatrizia Cavazzoni, Yoko Tanaka, Suraja M Roychowdhury, et al.
Journal of Psychiatric Research|September 23, 2008
Bayesian adaptive non-inferiority with safety assessment: retrospective case study to highlight potential benefits and limitations of the approachMelissa Spann, Stacy Lindborg, John Seaman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 17, 2005
Diabetes mellitus and antipsychotic treatment in the United KingdomChristopher Carlson, Kenneth Hornbuckle, Frank DeLisle, et al.
Psychiatric Services (Washington, D.C.)|October 4, 2016
Utilization and Cost of Health Care Services During the First Episode of PsychosisEmily Liffick, Nicole F Mehdiyoun, Jenifer L Vohs, et al.
Journal of Clinical Epidemiology|March 26, 2003
A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United StatesJohn B Buse, Patrizia Cavazzoni, Kenneth Hornbuckle, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Psychopharmacology|April 10, 2023
Evidence of trospium's ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study resultsAlan Breier, Stephen K Brannan, Steven M Paul, et al.
Early Intervention in Psychiatry|November 29, 2023
Early phase psychosis and criminal conviction in United States adultsKyle D Webster, Tracy D Gunter, Jenifer L Vohs, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 19, 2002
Amphetamine-induced dopamine release and post-synaptic specific binding in patients with mild tardive dyskinesiaCaleb M Adler, Anil K Malhotra, Igor Elman, et al.
The Journal of Clinical Psychiatry|April 11, 2025
Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia: PANSS-Excited Component Results From 3 Randomized, Double-Blind, Placebo-Controlled EMERGENT TrialsPaul P Yeung, Alan Breier, Haiyuan Zhu, et al.
The American Journal of Psychiatry|August 6, 2003
The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumesCelso Arango, Alan Breier, Robert McMahon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 26, 2003
Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trialPatrizia Cavazzoni, Yoko Tanaka, Suraja M Roychowdhury, et al.
Journal of Psychiatric Research|September 23, 2008
Bayesian adaptive non-inferiority with safety assessment: retrospective case study to highlight potential benefits and limitations of the approachMelissa Spann, Stacy Lindborg, John Seaman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 17, 2005
Diabetes mellitus and antipsychotic treatment in the United KingdomChristopher Carlson, Kenneth Hornbuckle, Frank DeLisle, et al.
Psychiatric Services (Washington, D.C.)|October 4, 2016
Utilization and Cost of Health Care Services During the First Episode of PsychosisEmily Liffick, Nicole F Mehdiyoun, Jenifer L Vohs, et al.
Journal of Clinical Epidemiology|March 26, 2003
A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United StatesJohn B Buse, Patrizia Cavazzoni, Kenneth Hornbuckle, et al.
Pageof 11